Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...

The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and ...

The motor neuron disease treatment market is witnessing substantial growth, primarily fueled by the rising incidence of conditions like Amyotrophic L ...

Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

Researchers in Shanghai have made a major clinical-stage breakthrough in brain-computer interfaces (BCI) researches by ...

Motor neurone disease (MND) is a rare but progressive neurological disorder characterised by the degeneration of motor ...

Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare ...

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...